Novo Nordisk A/S | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
Bausch Health Companies USD 867M 47M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
Merck USD 2.53B 319M 2025-03
Novartis USD 3.5B 368M 2024-12
Novo Nordisk 16.11B 480M 2025-03
Novo Nordisk DKK 16.59B 501M 2024-09
Pacira USD 86.78M 7.16M 2025-03
Sanofi EUR 2.22B 980M 2025-03
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12



Novo Nordisk A/S Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - May 2025.